Tetraphase announces positive top-line results from phase 3 IGNITE4 clinical trial
Tetraphase announced positive top-line results from IGNITE4, the Company's phase 3 clinical trial evaluating the efficacy and safety of twice-daily intravenous (IV) eravacycline compared to meropenem for the treatment of patients with complicated intra-abdominal infections. July 25, 2017